These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7533567)

  • 1. Possible mechanisms of pharmacological neuronal protection.
    Cottrell JE
    J Neurosurg Anesthesiol; 1995 Jan; 7(1):31-7. PubMed ID: 7533567
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain tissue responses to ischemia.
    Lee JM; Grabb MC; Zipfel GJ; Choi DW
    J Clin Invest; 2000 Sep; 106(6):723-31. PubMed ID: 10995780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects].
    Mahura IS
    Fiziol Zh (1994); 2003; 49(2):7-12. PubMed ID: 12945108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection, excitotoxicity and NMDA antagonists.
    Gagliardi RJ
    Arq Neuropsiquiatr; 2000 Jun; 58(2B):583-8. PubMed ID: 10920427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic stroke: "acidotoxicity" is a perpetrator.
    Huang Y; McNamara JO
    Cell; 2004 Sep; 118(6):665-6. PubMed ID: 15369664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antioxidants as neuroprotective agents for the treatment of ischemic brain injury and neurodegenerative diseases].
    Belousova MA; Korsakova EA; Gorodetskaia EA; Kalenikova EI; Medvedev OS
    Eksp Klin Farmakol; 2014; 77(11):36-44. PubMed ID: 25668946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral protection by pharmacological agents (author's transl)].
    Asano T; Sano K
    No Shinkei Geka; 1979 Jun; 7(6):549-54. PubMed ID: 381962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebral ischemia, anesthetic agents and cerebral metabolic protection].
    Roquefeuil B
    Agressologie; 1987 Mar; 28(3):309-14. PubMed ID: 3618888
    [No Abstract]   [Full Text] [Related]  

  • 9. Barbiturates as protective agents in brain ischemia and as free radical scavengers in vitro.
    Smith DS; Rehncrona S; Siesjö BK
    Acta Physiol Scand Suppl; 1980; 492():129-34. PubMed ID: 6939303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic principles of cerebral protection in humans.
    Lanier WL
    Liver Transpl Surg; 1999 Jul; 5(4):347-9. PubMed ID: 10388512
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death.
    Meloni BP; Majda BT; Knuckey NW
    Brain Res; 2002 Feb; 928(1-2):69-75. PubMed ID: 11844473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of anesthetic agents.
    Kawaguchi M; Furuya H; Patel PM
    J Anesth; 2005; 19(2):150-6. PubMed ID: 15875133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of oxidative DNA damage with a novel antioxidant EPC-K1 in rat brain neuronal cells after transient middle cerebral artery occlusion.
    Zhang WR; Hayashi T; Sasaki C; Sato K; Nagano I; Manabe Y; Abe K
    Neurol Res; 2001 Sep; 23(6):676-80. PubMed ID: 11547942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidotoxicity trumps excitotoxicity in ischemic brain.
    Simon RP
    Arch Neurol; 2006 Oct; 63(10):1368-71. PubMed ID: 17030650
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current role of barbiturates in cerebral protection].
    Siani C; Briano G; Gentile T; Cormio M
    Minerva Anestesiol; 1993 Oct; 59(10 Suppl 3):59-62. PubMed ID: 8290109
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia.
    Lysko PG; Webb CL; Yue TL; Gu JL; Feuerstein G
    Stroke; 1994 Dec; 25(12):2476-82. PubMed ID: 7974592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
    Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?
    Weiser T
    Curr Pharm Des; 2002; 8(10):941-51. PubMed ID: 11945140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channels as targets for neuroprotective agents.
    Narahashi T; Huang CS; Song JH; Yeh JZ
    Ann N Y Acad Sci; 1997 Oct; 825():380-8. PubMed ID: 9370002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of the protective effects of calcium antagonists and barbiturates on cerebral energy metabolites and cyclic AMP during and after forebrain ischemia in gerbils].
    Murakami N
    Neurol Med Chir (Tokyo); 1987 May; 27(5):381-9. PubMed ID: 2446175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.